Detailed View
OLMA - Olema Pharmaceuticals, Inc.
Latest filing: 2026-03-31 | Reporting: gaap
Market Cap
1,114,553,728
Adj EBIT (TTM)
-201,811,000
Enterprise Value
609,206,728
Last Price
12.76
Earnings Yield
-33.13%
Return on Capital
-41.74%
Capital
483,478,000
1Y Price Chart
Last Price: $12.76
1Y Change: 157.26%
As of 2026-05-28 | 1Y Change: 157.26%
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-03-31 | 10-Q | 2026 | 0 | -57,986,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 0 | -50,084,000 |
| 2025-09-30 | 10-Q | 2025 | 0 | -45,877,000 |
| 2025-06-30 | 10-Q | 2025 | 0 | -47,864,000 |
| 2025-03-31 | 10-Q | 2025 | 0 | -34,873,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 0 | -36,768,000 |
| 2024-09-30 | 10-Q | 2024 | 0 | -37,621,000 |
| 2024-06-30 | 10-Q | 2024 | 0 | -33,530,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.